CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Net revenues	$ 41,575,480	$ 12,371,673
Costs and expenses
Cost of services	40,239,642	10,133,005
General and administrative	4,889,184	3,836,475
Depreciation and amortization	155,267	164,658
Total costs and expenses	45,284,093	14,134,138
Loss from operations	(3,708,613)	(1,762,465)
Other (expense) income:
Interest expense	(192,989)	(2,659)
Gain on change in fair value of warrant liability	0	822,222
Other income	38,657	1,971
Total other (expense) income, net	(154,332)	821,534
Loss before benefit from income taxes	(3,862,945)	(940,931)
Benefit from income taxes	(29,891)	(41,553)
Net loss	(3,833,054)	(899,378)
Net loss (income) attributable to non-controlling interest	221,242	(415,879)
Net loss attributable to Apollo Medical Holdings, Inc.	$ (3,611,812)	$ (1,315,257)
Net loss per share:
Basic and diluted	$ (0.60)	$ (0.22)
Weighted average number of shares of common stock outstanding:
Basic and diluted	6,033,518	5,914,826